Congenital Varicella Syndrome (CVS)
Q1: What is Congenital Varicella Syndrome (CVS) and how does it happen?
- Alternative Name Also known as Fetal Varicella Syndrome.
- Core Definition Rare group of congenital structural abnormalities from intrauterine Varicella-Zoster Virus (VZV) infection.
- Maternal Trigger Follows maternal primary varicella (chickenpox) during pregnancy.
- Pathogenesis Fetal viral infection damages developing tissues: skin, limbs, central nervous system, and eyes.
- Herpes Zoster Rule Maternal herpes zoster (shingles) is generally not associated with fetal harm (not equivalent to primary varicella).
Q2: When is the risk of fetal abnormalities highest during pregnancy?
- Overall Window Risk is greatest during the first 20 weeks of gestation (overall absolute risk is low).
- First 12–13 Weeks Absolute risk of CVS is approximately 0.4–0.5%.
- Weeks 13 to 20 Peak risk window: approximately 2% risk of congenital abnormalities.
- After 20 Weeks Very uncommon after 20 weeks; rare cases reported as late as 28 weeks.
- Statistical Caveat Percentages reflect risk of congenital abnormalities, NOT overall probability of fetal infection.
- Peripartum Window Maternal rash from 5 days before to 2 days after delivery causes severe acute Neonatal Varicella (lack of maternal antibodies).
Q3: What are the clinical features across the 5 organ systems?
- Presentation Rule Manifestations vary; absence of one characteristic feature does NOT exclude CVS.
- 1. Cutaneous (Skin) Atrophic, depressed, linear/irregular cicatricial scars; hypo/hyperpigmented lesions; dermatomal/segmental pattern; localized skin/subcutaneous atrophy. Usually healed/healing scars at birth (NOT active vesicles).
- 2. Musculoskeletal Limb hypoplasia/shortening, localized muscle atrophy, asymmetry/deformities, finger/toe abnormalities, clubfoot (often matches dermatomal skin areas).
- 3. Ocular (Eyes) Chorioretinitis, chorioretinal scarring, congenital cataracts, microphthalmia, optic nerve abnormalities/atrophy, nystagmus, visual impairment.
- 4. Neurological Microcephaly, cortical atrophy, encephalitis, seizures, developmental/intellectual disability, abnormal tone, limb paresis, spinal cord defects, Horner syndrome.
- 4b. Autonomic NS Neurogenic bladder and gastrointestinal dysmotility.
- 5. Systemic / Other Intrauterine growth restriction (IUGR), low birth weight, prematurity, GI or genitourinary abnormalities.
- الجلد: ندبات ضامرة أو غائرة (Cicatricial scars) تتبع مسار الأعصاب (Dermatomal)، وتكون ندبات ملتئمة عند الولادة وليست حويصلات نشطة.
- الأطراف: نقص تنسج أو قصر الأطراف (Hypoplasia)، ضمور عضلي موضعي، وحنف القدم (Clubfoot).
- العين: التهاب المشيمية والشبكية، ساد خلقي (Cataracts)، صغر العين (Microphthalmia)، ضمور العصب البصري، ورأرأة.
- الأعصاب: صغر الرأس، ضمور قشري دماغي، اختلاجات، متلازمة هورنر، وإصابة الجهاز العصبي الذاتي (مثانة عصبية واضطراب حركة الأمعاء).
- عامة: تقييد النمو داخل الرحم (IUGR)، نقص وزن الولادة، والولادة المبكرة.
Q4: How is CVS diagnosed prenatally and postnatally, and what are its mimics?
- Maternal Confirmation History of primary maternal varicella + maternal VZV serology (if uncertain) + PCR of maternal skin lesions (for acute confirmation).
- Ultrasound Timing Begin serial fetal ultrasound ~5 weeks after maternal infection OR from 16 weeks of gestation, whichever is earlier.
- Fetal Imaging Targets Ultrasound checks growth, limbs, and brain; Fetal MRI evaluates suspected CNS abnormalities.
- Amniotic Fluid PCR Positive VZV PCR confirms fetal infection, NOT CVS itself; negative PCR does NOT completely exclude CVS.
- Postnatal Workup Examine skin scars, limb length/joints, eyes, neuro/head circumference + cranial imaging, hearing, renal, and GI evaluations.
- Differential Diagnosis Congenital CMV, Congenital Rubella, Congenital Toxoplasmosis, Neonatal HSV, Amniotic band sequence, other limb-reduction/cutaneous disorders.
Q5: How do we prevent and manage CVS, and what is the prognosis?
- Structural Damage Rule No specific antiviral reverses established congenital structural abnormalities.
- IV Acyclovir Role Used for active neonatal varicella infection; does NOT correct established congenital damage.
- Supportive Team Multidisciplinary: neonatology, dermatology, ophthalmology, neurology, orthopedics, developmental therapy + growth/hearing/renal monitoring.
- Vaccine Timing Vaccinate non-immune women before pregnancy or postpartum; live attenuated vaccine is contraindicated during pregnancy.
- VariZIG Prophylaxis Give VariZIG to susceptible exposed pregnant women as soon as possible, within 10 days of exposure.
- Maternal Antivirals Pregnant women who develop varicella need prompt assessment; antiviral treatment may be considered under specialist guidance.
- Prognosis Depends on organ severity (ranges from limited abnormalities to permanent visual, limb, neuro, or developmental disability); early rehab improves function.
Confusable Concepts & Disambiguation Matrices
High-yield side-by-side contrasts designed to eliminate exam traps.
1. Congenital Varicella Syndrome (CVS) vs. Neonatal Varicella
| Feature | Congenital Varicella Syndrome (CVS) | Neonatal Varicella |
|---|---|---|
| Timing of Maternal Infection | During pregnancy, greatest in first 20 weeks (peak 13–20 weeks). | Around delivery: high risk when maternal rash appears 5 days before to 2 days after delivery. |
| Core Nature of Disease | Established congenital structural abnormalities across organ systems. | Severe acute infection in the newborn (insufficient maternal antibodies). |
| Cutaneous Appearance | Usually healed or healing cicatricial scars along dermatomes at birth. | Acute vesicular eruption of active infection. |
| Role of IV Acyclovir | Does NOT reverse established congenital structural damage. | Indicated for managing active neonatal varicella infection. |
2. Diagnostic & Prevention Disambiguation
| Confusable Pair / Trio | Exact Rule from Source | Exam Pitfall to Avoid |
|---|---|---|
| Primary Maternal Varicella vs. Maternal Herpes Zoster | Primary varicella causes CVS (0.4–0.5% <13w; 2% 13–20w). Maternal herpes zoster (shingles) is generally not associated with fetal harm. | Never equate maternal shingles with primary chickenpox during pregnancy. |
| Amniotic Fluid VZV PCR (+) vs. PCR (-) | Positive PCR: Confirms fetal infection, NOT presence of CVS. Negative PCR: Does not completely exclude CVS. | Do not diagnose structural CVS solely from a positive amniotic PCR, nor rule it out completely on a negative PCR. |
| Varicella Vaccine vs. VariZIG vs. Antivirals | Vaccine: Pre-pregnancy & postpartum (contraindicated in pregnancy). VariZIG: Post-exposure for susceptible pregnant women within 10 days. Antivirals: For pregnant women who develop varicella (specialist guidance) or active neonatal varicella. | Never give live attenuated varicella vaccine to a pregnant patient; use VariZIG for post-exposure prophylaxis. |
- CVS مقابل الحماق الوليدي: الـ CVS هي تشوهات خلقية بنيوية تحدث بسبب العدوى المبكرة (أول 20 أسبوعاً) وتظهر كندبات ملتئمة ولا يعكسها الأسيكلوفير. أما الحماق الوليدي (Neonatal Varicella) فهو عدوى حادة خطيرة تحدث قرب الولادة (-5 أيام إلى +2 يوم) وتعالج بالأسيكلوفير الوريدي.
- الحماق الأولي مقابل الحزام الناري: الحماق الأولي يسبب المتلازمة، بينما الحزام الناري (Herpes Zoster) لا يرتبط عموماً بأذى الجنين.
- فحص PCR للسائل الأمنيوسي: النتيجة الإيجابية تثبت وصول الفيروس للجنين فقط وليس حدوث التشوهات، والنتيجة السلبية لا تستبعد المتلازمة بنسبة 100%.
Select the exact term inside the brackets, then click Check Answers to verify.
Click a number badge from the top bank, then click its matching clinical rule below.
Click a clinical finding chip below, then click its correct category bucket. Instant feedback is provided!
Click the card (or press Space) to flip. Marking Still Learning re-queues the card so you review weak items first.
⚡ Exam-Eve Ultra-Rapid Keyword Sheet (60-Second Scan)
| Domain | Stripped High-Yield Keywords |
|---|---|
| Etiology & Risk | Primary maternal varicella • First 20w • Wks 0–12/13: 0.4–0.5% • Wks 13–20: 2% (Peak) • >20w: rare (up to 28w) • Zoster = No fetal harm. |
| Skin & Limbs | Cicatricial atrophic scars • Dermatomal • Healed at birth (no vesicles) • Limb hypoplasia • Muscle atrophy • Clubfoot. |
| Eyes & CNS | Chorioretinitis • Congenital cataracts • Microphthalmia • Optic atrophy • Microcephaly • Cortical atrophy • Horner syndrome • Neurogenic bladder • GI dysmotility. |
| Diagnosis | Maternal serology & lesion PCR • Serial US at ~5w post-infection OR 16w gestation (whichever is earlier) • Fetal MRI for CNS • Amniotic PCR (+) = fetal infection, NOT CVS itself. |
| Management & Prevention | Structural defects = irreversible by antivirals • IV Acyclovir = active neonatal varicella • Peripartum high-risk rash = -5d to +2d • Vaccine = contraindicated in pregnancy • VariZIG within 10 days. |
📚 Consolidated Source References (Compiled: November 13, 2026)
- Centers for Disease Control and Prevention (CDC). Chapter 22: Varicella. Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book). https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-22-varicella.html
- Centers for Disease Control and Prevention (CDC). Clinical Guidance for People at Risk for Severe Varicella. https://www.cdc.gov/chickenpox/hcp/clinical-guidance/
- Khalil A, Sotiriadis A, Chaoui R, et al. ISUOG Practice Guidelines: role of ultrasound in congenital infection. Ultrasound Obstet Gynecol. 2020;56(1):128–151. doi:10.1002/uog.21991
- Singh S, Sharma A, Rahman MM, et al. Congenital and Perinatal Varicella Infections. Newborn. 2022;1(3):278–286. https://pmc.ncbi.nlm.nih.gov/articles/PMC9762609/
- Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343:1548–1551. doi:10.1016/S0140-6736(94)92943-2